• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据来源地区、性别和艾滋病毒感染组,法国抗逆转录病毒治疗中的病毒反弹情况。法国医院艾滋病毒数据库(ANRS CO4-FHDH)的结果。

Viral rebound on antiretroviral therapy in France according to region of origin, sex, and HIV acquisition group. Results from the French Hospital Database on HIV (ANRS CO4-FHDH).

作者信息

Abgrall S, Selinger-Leneman H, Lanoy E, Becker A, Matheron S, de Truchis P, Pavie J, Canestri A, Khuong M A, Rey D, Caby F, Tattevin P, Palich R, Grabar S

机构信息

AP-HP, Hôpital Béclère, Service de Médecine Interne, Clamart, and Université Paris-Saclay, CESP INSERM U1018, Le Kremlin-Bicêtre, France.

Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.

出版信息

HIV Med. 2025 Feb;26(2):252-264. doi: 10.1111/hiv.13729. Epub 2024 Nov 4.

DOI:10.1111/hiv.13729
PMID:39497481
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11786615/
Abstract

BACKGROUND

Assessing the potential increased risk of viral rebound (VR) in migrants requires adequate control for sex and acquisition risk groups.

METHODS

People living with HIV1, enrolled in the ANRS CO4-French Hospital Database on HIV, who achieved virological suppression with antiretroviral therapy (ART) initiated between 2006 and 2016 were included. We first compared the risk of VR, with loss to follow-up and death considered as competing events, across origin among the HIV acquisition groups, then across acquisition groups among the different origins, and finally across modality of a variable combining sex, acquisition group, and origin. Models were adjusted for clinical and biological confounding factors.

RESULTS

We included 21 571 French natives (FRA), 10 148 migrants from sub-Saharan Africa (SSA), 1137 migrants from the non-French West Indies (NFWI), and 4205 other migrants (OTHER). The 5-year probability of VR was 19% (95% confidence interval [CI] 19-20) overall, 15% in FRA, 21% in OTHER, 26% in SSA, and 34% in NFWI (p < 0.0001). It was 14% in men who have sex with men (MSM), 23% in heterosexual men, and 23% in women (p < 0.0001). After adjustment, all acquisition groups had a higher risk of VR than MSM from FRA, with men and women from NFWI having the highest risk (adjusted hazard ratio [aHR] 2.46; 95% CI 2.12-2.86 and aHR 2.59; 95% CI 2.20-3.04, respectively). Within each acquisition group, all groups of origin had a higher risk of VR than FRA. Within each region of origin, except the NFWI, heterosexual men had a higher risk of VR than MSM.

CONCLUSIONS

After accounting for sex and acquisition group, migration, especially from NFWI, remains prognostic of VR.

摘要

背景

评估移民中病毒反弹(VR)潜在增加的风险需要对性别和感染风险群体进行充分控制。

方法

纳入了参加ANRS CO4 - 法国医院HIV数据库的HIV - 1感染者,这些感染者在2006年至2016年期间开始接受抗逆转录病毒治疗(ART)并实现了病毒学抑制。我们首先比较了HIV感染群体中不同来源的VR风险,并将失访和死亡视为竞争事件,然后比较了不同来源中不同感染群体的VR风险,最后比较了一个结合性别、感染群体和来源的变量的不同模式的VR风险。模型针对临床和生物学混杂因素进行了调整。

结果

我们纳入了21571名法国本土人(FRA)、10148名撒哈拉以南非洲移民(SSA)、1137名非法属西印度群岛移民(NFWI)和4205名其他移民(OTHER)。总体而言,VR的5年概率为19%(95%置信区间[CI] 19 - 20),FRA为15%,OTHER为21%,SSA为26%,NFWI为34%(p < 0.0001)。男男性行为者(MSM)为14%,异性恋男性为23%,女性为23%(p < 0.0001)。调整后,所有感染群体的VR风险均高于FRA的MSM,NFWI的男性和女性风险最高(调整后风险比[aHR]分别为2.46;95% CI 2.12 - 2.86和aHR 2.59;95% CI 2.20 - 3.04)。在每个感染群体中,所有来源组的VR风险均高于FRA。在每个原籍地区域内,除NFWI外,异性恋男性的VR风险高于MSM。

结论

在考虑性别和感染群体后,移民,尤其是来自NFWI的移民,仍然是VR的预后因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92e6/11786615/17c65d6b6e0c/HIV-26-252-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92e6/11786615/8fb7e63f7543/HIV-26-252-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92e6/11786615/bbbf8cea8073/HIV-26-252-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92e6/11786615/17c65d6b6e0c/HIV-26-252-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92e6/11786615/8fb7e63f7543/HIV-26-252-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92e6/11786615/bbbf8cea8073/HIV-26-252-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92e6/11786615/17c65d6b6e0c/HIV-26-252-g001.jpg

相似文献

1
Viral rebound on antiretroviral therapy in France according to region of origin, sex, and HIV acquisition group. Results from the French Hospital Database on HIV (ANRS CO4-FHDH).根据来源地区、性别和艾滋病毒感染组,法国抗逆转录病毒治疗中的病毒反弹情况。法国医院艾滋病毒数据库(ANRS CO4-FHDH)的结果。
HIV Med. 2025 Feb;26(2):252-264. doi: 10.1111/hiv.13729. Epub 2024 Nov 4.
2
Later cART initiation in migrant men from sub-Saharan Africa without advanced HIV disease in France.法国针对撒哈拉以南非洲地区无晚期艾滋病的移民男性较晚开始抗逆转录病毒治疗。
PLoS One. 2015 Mar 3;10(3):e0118492. doi: 10.1371/journal.pone.0118492. eCollection 2015.
3
Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in France.地理起源对法国异性恋 HIV 感染者 cART 期间 AIDS 和严重非 AIDS 发病率/死亡率的影响。
PLoS One. 2018 Oct 31;13(10):e0205385. doi: 10.1371/journal.pone.0205385. eCollection 2018.
4
Elevated risk of viral rebound on ART in migrants living in France: role of socioeconomic factors.居住在法国的移民接受抗逆转录病毒治疗(ART)后病毒反弹风险升高:社会经济因素的作用。
Antivir Ther. 2019;24(7):541-552. doi: 10.3851/IMP3339.
5
Influence of geographic origin, sex, and HIV transmission group on the outcome of first-line combined antiretroviral therapy in France.地理来源、性别及HIV传播途径对法国一线联合抗逆转录病毒治疗结果的影响。
AIDS. 2016 Sep 10;30(14):2235-46. doi: 10.1097/QAD.0000000000001193.
6
Factors Associated with Virological Rebound in HIV-Positive Sub-Saharan Migrants Living in France After Traveling Back to Their Native Country: ANRS-VIHVO 2006-2009 Study.回到原籍国后居住在法国的撒哈拉以南地区艾滋病毒阳性移民中与病毒学反弹相关的因素:法国国家艾滋病研究机构 - 艾滋病毒观察站2006 - 2009年研究。
J Immigr Minor Health. 2019 Dec;21(6):1342-1348. doi: 10.1007/s10903-019-00864-y.
7
Does region of origin influence the timing and outcome of first-line antiretroviral therapy in France?起源地区是否会影响法国一线抗逆转录病毒治疗的时机和结果?
HIV Med. 2019 Feb;20(2):175-181. doi: 10.1111/hiv.12697. Epub 2018 Dec 3.
8
Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?西欧移民和本地男女接受抗逆转录病毒治疗的免疫和病毒学反应;所有人群都能平等受益吗?
HIV Med. 2018 Jan;19(1):42-48. doi: 10.1111/hiv.12536. Epub 2017 Jul 25.
9
Prevalence and circumstances of forced sex and post-migration HIV acquisition in sub-Saharan African migrant women in France: an analysis of the ANRS-PARCOURS retrospective population-based study.撒哈拉以南非洲移民女性在法国的被迫性行为和移民后 HIV 感染的流行情况和环境:对 ANRS-PARCOURS 回顾性基于人群的研究的分析。
Lancet Public Health. 2018 Jan;3(1):e16-e23. doi: 10.1016/S2468-2667(17)30211-6. Epub 2017 Nov 23.
10
Travel-related health events and their risk factors in HIV-infected sub-Saharan migrants living in France and visiting their native country: The ANRS VIHVO cohort study.在法居住、返乡的撒哈拉以南 HIV 感染者的旅行相关健康事件及其危险因素:法国 ANRS VIHVO 队列研究。
Travel Med Infect Dis. 2019 May-Jun;29:40-47. doi: 10.1016/j.tmaid.2019.03.010. Epub 2019 Apr 2.

本文引用的文献

1
Management of low-level HIV viremia during antiretroviral therapy: Delphi consensus statement and appraisal of the evidence.抗逆转录病毒治疗期间低水平 HIV 病毒血症的管理:德尔菲共识声明和证据评估。
Sex Transm Infect. 2024 Oct 17;100(7):442-449. doi: 10.1136/sextrans-2024-056199.
2
Low Level Viremia Is Associated With Serious non-AIDS Events in People With HIV.低水平病毒血症与HIV感染者的严重非艾滋病事件相关。
Open Forum Infect Dis. 2024 Mar 30;11(4):ofae147. doi: 10.1093/ofid/ofae147. eCollection 2024 Apr.
3
Striking differences in weight gain after cART initiation depending on early or advanced presentation: results from the ANRS CO4 FHDH cohort.
根据早期或晚期诊断,开始 cART 后体重增加存在显著差异:来自 ANRS CO4 FHDH 队列的结果。
J Antimicrob Chemother. 2023 Mar 2;78(3):757-768. doi: 10.1093/jac/dkad007.
4
Differences in HIV clinical outcomes amongst heterosexuals in the United Kingdom by ethnicity.英国不同族裔异性恋人群中 HIV 临床结局的差异。
AIDS. 2021 Sep 1;35(11):1813-1821. doi: 10.1097/QAD.0000000000002942.
5
Enhanced immunovirological response in women compared to men after antiretroviral therapy initiation during acute and early HIV-1 infection: results from a longitudinal study in the French ANRS Primo cohort.在急性和早期 HIV-1 感染期间开始抗逆转录病毒治疗后,女性的免疫病毒学反应优于男性:法国 ANRS Primo 队列的纵向研究结果。
J Int AIDS Soc. 2020 Apr;23(4):e25485. doi: 10.1002/jia2.25485.
6
Elevated risk of viral rebound on ART in migrants living in France: role of socioeconomic factors.居住在法国的移民接受抗逆转录病毒治疗(ART)后病毒反弹风险升高:社会经济因素的作用。
Antivir Ther. 2019;24(7):541-552. doi: 10.3851/IMP3339.
7
Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials.抗逆转录病毒治疗起始后体重增加:随机对照临床试验中的危险因素。
Clin Infect Dis. 2020 Sep 12;71(6):1379-1389. doi: 10.1093/cid/ciz999.
8
Factors Associated with Virological Rebound in HIV-Positive Sub-Saharan Migrants Living in France After Traveling Back to Their Native Country: ANRS-VIHVO 2006-2009 Study.回到原籍国后居住在法国的撒哈拉以南地区艾滋病毒阳性移民中与病毒学反弹相关的因素:法国国家艾滋病研究机构 - 艾滋病毒观察站2006 - 2009年研究。
J Immigr Minor Health. 2019 Dec;21(6):1342-1348. doi: 10.1007/s10903-019-00864-y.
9
Impact of baseline plasma HIV-1 RNA and time to virological suppression on virological rebound according to first-line antiretroviral regimen.根据一线抗逆转录病毒治疗方案,基线血浆 HIV-1 RNA 和达到病毒学抑制时间对病毒学反弹的影响。
J Antimicrob Chemother. 2017 Dec 1;72(12):3425-3434. doi: 10.1093/jac/dkx300.
10
Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?西欧移民和本地男女接受抗逆转录病毒治疗的免疫和病毒学反应;所有人群都能平等受益吗?
HIV Med. 2018 Jan;19(1):42-48. doi: 10.1111/hiv.12536. Epub 2017 Jul 25.